Advanced glycation endproducts and diabetes. beyond vascular complications

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 2, 2011, Pages 132-140

  Puddu, Alessandra ^a   Viviani, Giorgio L ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Advanced glycation end products; Diabetes; Insulin resistance; Pancreatic cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; INSULIN;

ARTICLE; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION;

EID: 79956269824     PISSN: 18715303     EISSN: 18715303     Source Type: Journal    
DOI: 10.2174/187153011795564115     Document Type: Article

References (101)

1. Lin, Y. and Sun, Z. (2010) Current views on type 2 diabetes. J. Endocrinol., 204, 1-11.
2. Singh, R., Barden, A., Mori, T. and Beilin, L. (2001) Advanced glycation end-products: a review. Diabetologia, 44, 129-146.
3. Meerwaldt, R., Links, T., Zeebregts, C., Tio, R., Hillebrands, J. L. and Smit, A. (2008) The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc. Diabetol., 7, 29.
4. Thornalley, P.J. (1990) The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J., 269, 1-11.
5. Lyons, T.J. and Jenkins, A.J. (1997) Lipoprotein glycation and its metabolic consequences. Curr. Opin. Lipidol., 8, 174-180.
6. Monnier, V.M. (1990) Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol., 45, B105-111.
7. John, W.G. and Lamb, E.J. (1993) The Maillard or browning reaction in diabetes. Eye (Lond)., 7 (Pt 2), 230-237.
8. Ahmed, M.U., Thorpe, S.R. and Baynes, J.W. (1986) Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem., 261, 4889-4894.
9. Sell, D.R., Nagaraj, R.H., Grandhee, S.K., Odetti, P., Lapolla, A., Fogarty, J. and Monnier, V.M. (1991) Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab. Rev., 7, 239-251.
10. Biemel, K.M., Reihl, O., Conrad, J. and Lederer, M.O. (2001) Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor. J. Biol. Chem., 276, 23405-23412.
11. Chellan, P. and Nagaraj, R.H. (2001) Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation. J. Biol. Chem., 276, 3895-3903.
12. Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R. and Cerami, A. (1997) Tobacco smoke is a source of toxic reactive glycation products. Proc. Natl. Acad. Sci. USA, 94, 13915-13920.
13. Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M. and Rayfield, E.J. (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc. Natl. Acad. Sci. USA, 99, 15596-15601.
14. Vlassara, H. and Striker, G. (2007) Glycotoxins in the diet promote diabetes and diabetic complications. Curr. Diab. Rep., 7, 235-241.
15. Sebekova, K., Krajcoviova-Kudlackova, M., Schinzel, R., Faist, V., Klvanova, J. and Heidland, A. (2001) Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur. J. Nutr., 40, 275-281.
16. Vlassara, H. (2005) Advanced glycation in health and disease: role of the modern environment. Ann. N.Y. Acad. Sci., 1043, 452-460.
17. Li, G., Zhang, P., Wang, J., Gregg, E.W., Yang, W., Gong, Q., Li, H., Jiang, Y., An, Y., Shuai, Y., Zhang, B., Zhang, J., Thompson, T.J., Gerzoff, R.B., Roglic, G., Hu, Y. and Bennett, P.H. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet, 371, 1783-1789.
18. Baynes, J.W. and Thorpe, S.R. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48, 1-9.
19. DeGroot, J. (2004) The AGE of the matrix: chemistry, consequence and cure. Curr. Opin. Pharmacol., 4, 301-305.
20. Goh, S.Y. and Cooper, M.E. (2008) Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab., 93, 1143-1152.
21. Hammes, H.P. (2003) Pathophysiological mechanisms of diabetic angiopathy. J. Diabetes Comp., 17, 16-19.
22. Thorpe, S.R. and Baynes, J.W. (1996) Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging, 9, 69-77.
23. Schmidt, A.M., Yan, S.D., Yan, S.F. and Stern, D.M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta, 1498, 99-111.
24. Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G. and Vlassara, H. (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J. Gerontol. A. Biol. Sci. Med. Sci., 62, 427-433.
25. Vlassara, H. (2001) The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev., 17, 436-443.
26. Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M. and Horiuchi, S. (1995) Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem., 230, 408-415.
27. Coux, O., Tanaka, K. and Goldberg, A.L. (1996) Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem., 65, 801-847.
28. Grune, T., Reinheckel, T. and Davies, K.J. (1997) Degradation of oxidized proteins in mammalian cells. Faseb. J., 11, 526-534.
29. Bulteau, A.L., Verbeke, P., Petropoulos, I., Chaffotte, A.F. and Friguet, B. (2001) Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. J. Biol. Chem., 276, 45662-45668.
30. Moheimani, F., Morgan, P.E., van Reyk, D.M. and Davies, M.J. Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis. Biochim. Biophys. Acta, 1802, 561-571.
31. Grimm, S., Ernst, L., Grotzinger, N., Hohn, A., Breusing, N., Reinheckel, T. and Grune, T. (2010) Cathepsin D is one of the major enzymes involved in intracellular degradation of AGE-modified proteins. Free Radic. Res., 44, 1013-1026.
32. Gugliucci, A. and Bendayan, M. (1996) Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia, 39, 149-160.
33. Gugliucci, A., Mehlhaff, K., Kinugasa, E., Ogata, H., Hermo, R., Schulze, J. and Kimura, S. (2007) Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Clin. Chim. Acta., 377, 213-220.
34. Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K. and Kinoshita, T. (1993) beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest., 92, 1243-1252.
35. Ahmed, N. and Thornalley, P.J. (2007) Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab., 9, 233-245.
36. Genuth, S., Sun, W., Cleary, P., Sell, D.R., Dahms, W., Malone, J., Sivitz, W. and Monnier, V.M. (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes, 54, 3103-3111.
37. Bohlender, J.M., Franke, S., Stein, G. and Wolf, G. (2005) Advanced glycation end products and the kidney. Am. J. Physiol. Renal. Physiol., 289, F645-659.
38. Hirata, K. and Kubo, K. (2004) Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes. Endocr. J., 51, 537-544.
39. Saisho, Y., Maruyama, T., Hirose, H. and Saruta, T. (2007) Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects. Diabetes Res. Clin. Pract., 78, 182-188.
40. Lonn, E., Yusuf, S., Hoogwerf, B., Pogue, J., Yi, Q., Zinman, B., Bosch, J., Dagenais, G., Mann, J.F. and Gerstein, H.C. (2002) Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care, 25, 1919-1927.
41. Monacelli, F., Poggi, A., Storace, D., Durante, A., Traverso, N., Viviani, G.L. and Odetti, P. (2006) Effects of valsartan therapy on protein glycoxidation. Metabolism, 55, 1619-1624.
42. Stumvoll, M., Goldstein, B.J. and van Haeften, T.W. (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 365, 1333-1346.
43. Flores-Riveros, J.R., McLenithan, J.C., Ezaki, O. and Lane, M.D. (1993) Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc. Natl. Acad. Sci. USA, 90, 512-516.
44. Ronnett, G.V., Knutson, V.P. and Lane, M.D. (1982) Insulininduced down-regulation of insulin receptors in 3T3-L1 adipocytes. Altered rate of receptor inactivation. J. Biol. Chem., 257, 4285-4291.
45. Kahn, B.B. and Flier, J.S. (2000) Obesity and insulin resistance. J. Clin. Invest., 106, 473-481.
46. Kuniyasu, A., Ohgami, N., Hayashi, S., Miyazaki, A., Horiuchi, S. and Nakayama, H. (2003) CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett., 537, 85-90.
47. Unno, Y., Sakai, M., Sakamoto, Y., Kuniyasu, A., Nakayama, H., Nagai, R. and Horiuchi, S. (2004) Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36. Biochem. Biophys. Res. Commun., 325, 151-156.
48. Uchida, Y., Ohba, K., Yoshioka, T., Irie, K., Muraki, T. and Maru, Y. (2004) Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J. Biol. Chem., 279, 4075-4083.
49. Chesne, S., Rondeau, P., Armenta, S. and Bourdon, E. (2006) Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie., 88, 1467-1477.
50. Singh, N.R., Rondeau, P., Hoareau, L. and Bourdon, E. (2007) Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin. Free Radic. Res., 41, 1078-1088.
51. Unoki, H., Bujo, H., Yamagishi, S., Takeuchi, M., Imaizumi, T. and Saito, Y. (2007) Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res. Clin. Pract., 76, 236-244.
52. Unoki-Kubota, H., Yamagishi, S., Takeuchi, M., Bujo, H. and Saito, Y. Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. Protein Pept. Lett., 17, 1177-1181.
53. Aguirre, V., Uchida, T., Yenush, L., Davis, R. and White, M. F. (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem., 275, 9047-9054.
54. Nakamori, Y., Emoto, M., Fukuda, N., Taguchi, A., Okuya, S., Tajiri, M., Miyagishi, M., Taira, K., Wada, Y. and Tanizawa, Y. (2006) Myosin motor Myo1c and its receptor NEMO/IKK-gamma promote TNF-alpha-induced serine307 phosphorylation of IRS-1. J. Cell. Biol., 173, 665-671.
55. Yoshida, T., Yamagishi, S., Matsui, T., Nakamura, K., Ueno, T., Takeuchi, M. and Sata, M. (2008) Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation. J. Int. Med. Res., 36, 237-243.
56. Dhar, A., Desai, K.M. and Wu, L. (2010) Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats. Br. J. Pharmacol., 159, 166-175.
57. Miele, C., Riboulet, A., Maitan, M.A., Oriente, F., Romano, C., Formisano, P., Giudicelli, J., Beguinot, F. and Van Obberghen, E. (2003) Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signalling through a protein kinase C alphamediated mechanism. J. Biol. Chem., 278, 47376-47387.
58. Riboulet-Chavey, A., Pierron, A., Durand, I., Murdaca, J., Giudicelli, J. and Van Obberghen, E. (2006) Methylglyoxal impairs the insulin signalling pathways independently of the formation of intracellular reactive oxygen species. Diabetes, 55, 1289-1299.
59. Cassese, A., Esposito, I., Fiory, F., Barbagallo, A.P., Paturzo, F., Mirra, P., Ulianich, L., Giacco, F., Iadicicco, C., Lombardi, A., Oriente, F., Van Obberghen, E., Beguinot, F., Formisano, P. and Miele, C. (2008) In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J. Biol. Chem., 283, 36088-36099.
60. Kume, S., Kato, S., Yamagishi, S., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M. and Nagata, K. (2005) Advanced glycation end-products attenuate human mesenchymal stem cellsand prevent cognate differentiation into adipose tissue, cartilage, and bone. J. Bone Miner Res., 20, 1647-1658.
61. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L. and Bevilacqua, S. (1987) Insulin resistance in essential hypertension. N. Engl. J. Med., 317, 350-357.
62. Thornalley, P.J. (1993) The glyoxalase system in health and disease. Mol. Aspects Med., 14, 287-371.
63. Beisswenger, P.J., Howell, S.K., Smith, K. and Szwergold, B.S. (2003) Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim. Biophys. Acta., 1637, 98-106.
64. Morgan, P.E., Dean, R.T. and Davies, M.J. (2002) Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch. Biochem. Biophys., 403, 259-269.
65. Chang, K.C., Paek, K.S., Kim, H.J., Lee, Y.S., Yabe-Nishimura, C. and Seo, H.G. (2002) Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol. Pharmacol., 61, 1184-1191.
66. Koh, G., Lee, D.H. and Woo, J.T. (2010) 2-Deoxy-D-ribose induces cellular damage by increasing oxidative stress and protein glycation in a pancreatic beta-cell line. Metabolism, 59, 325-332.
67. Kaneto, H., Fujii, J., Myint, T., Miyazawa, N., Islam, K.N., Kawasaki, Y., Suzuki, K., Nakamura, M., Tatsumi, H., Yamasaki, Y. and Taniguchi, N. (1996) Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem. J., 320, 855-863.
68. Lee, Y.J., Suh, K.S., Choi, M.C., Chon, S., Oh, S., Woo, J.T., Kim, S.W., Kim, J.W. and Kim, Y.S. (2010) Kaempferol protects HITT15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage. Phytother. Res., 24, 419-423.
69. Viviani, G.L., Puddu, A., Sacchi, G., Garuti, A., Storace, D., Durante, A., Monacelli, F. and Odetti, P. (2008) Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro. Metabolism, 57, 163-169.
70. Lim, M., Park, L., Shin, G., Hong, H., Kang, I. and Park, Y. (2008) Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann. N.Y. Acad. Sci., 1150, 311-315.
71. Ge, Q.M., Dong, Y. and Su, Q. (2010) Effects of glucose and advanced glycation end products on oxidative stress in MIN6 cells. Cell. Mol. Biol. (Noisy-le-grand), 56, OL1231-1238.
72. Zhao, Z., Zhao, C., Zhang, X. H., Zheng, F., Cai, W., Vlassara, H. and Ma, Z.A. (2009) Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology, 150, 2569-2576.
73. Puddu In: Beta Cells: Functions, Pathology & Research; Gallagher, S. E., Ed., NOVA Publishers: 2010; 95-112.
74. Poitout, V., Olson, L.K. and Robertson, R.P. (1996) Insulinsecreting cell lines: classification, characteristics and potential applications. Diabetes Metab., 22, 7-14.
75. Grankvist, K., Marklund, S.L. and Taljedal, I.B. (1981) CuZnsuperoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J., 199, 393-398.
76. Lenzen, S., Drinkgern, J. and Tiedge, M. (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med., 20, 463-466.
77. Lee, B.W., Chae, H.Y., Kwon, S.J., Park, S.Y., Ihm, J. and Ihm, S.H. (2010) RAGE ligands induce apoptotic cell death of pancreatic beta-cells via oxidative stress. Int. J. Mol. Med., 26, 813-818.
78. Zhu, Y., Shu, T., Lin, Y., Wang, H., Yang, J., Shi, Y. and Han, X. (2011) Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic beta-cells. Biochem. Biophys. Res. Commun., 404, 159-165.
79. Rorsman, P., Eliasson, L., Renstrom, E., Gromada, J., Barg, S. and Gopel, S. (2000) The Cell Physiology of Biphasic Insulin Secretion. News Physiol. Sci., 15, 72-77.
80. Puddu, A., Storace, D., Durante, A., Odetti, P. and Viviani, G.L. (2010) Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15. Biochem. Biophys. Res. Commun., 398, 462-466.
81. Tajiri, Y., Moller, C. and Grill, V. (1997) Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology, 138, 273-280.
82. Melloul, D., Marshak, S. and Cerasi, E. (2002) Regulation of insulin gene transcription. Diabetologia, 45, 309-326.
83. Matsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R. and Yamasaki, Y. (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest., 99, 144-150.
84. Puddu, A., Storace, D., Odetti, P. and Viviani, G.L. (2010) Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem. Biophys. Res. Commun., 395, 122-125.
85. Ostenson, C.G., Gaisano, H., Sheu, L., Tibell, A. and Bartfai, T. (2006) Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes, 55, 435-440.
86. Nagamatsu, S., Nakamichi, Y., Yamamura, C., Matsushima, S., Watanabe, T., Ozawa, S., Furukawa, H. and Ishida, H. (1999) Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes, 48, 2367-2373.
87. Puddu, A., Durante A., Poggi, A; Odetti, P., Viviani, G. L. (2005) Glycated serum decreases insulin content and modifies the expression of proteins involved in insulin granule exocytosis. Diabetes, 54, Suppl. 1, A653.
88. McKillop, A.M., Abdel-Wahab, Y.H., Mooney, M.H., O'Harte, F.P. and Flatt, P.R. (2002) Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity. Diabetes Metab., 28, 3S61-S69; discussion 63S108-112.
89. McKillop, A.M., Lindsay, J.R., Au, S., Mahood, K.I., O'Harte, F.P., Flatt, P.R. and Bell, P.M. (2006) Meal-dependent regulation of circulating glycated insulin in type 2 diabetic subjects. Horm. Metab. Res., 38, 94-97.
90. O'Harte, F.P., Hojrup, P., Barnett, C.R. and Flatt, P.R. (1996) Identification of the site of glycation of human insulin. Peptides, 17, 1323-1330.
91. Guedes, S., Vitorino, R., Domingues, M.R., Amado, F. and Domingues, P. (2010) Oxidative modifications in glycated insulin. Anal. Bioanal. Chem., 397, 1985-1995.
92. Lindsay, J.R., McKillop, A.M., Mooney, M.H., O'Harte, F.P., Flatt, P.R. and Bell, P.M. (2003) Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes. Diabetes Res. Clin. Pract., 61, 167-173.
93. Abdel-Wahab, Y.H., O'Harte, F.P., Ratcliff, H., McClenaghan, N.H., Barnett, C.R. and Flatt, P.R. (1996) Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes, 45, 1489-1496.
94. Abdel-Wahab, Y.H., O'Harte, F.P., Barnett, C.R. and Flatt, P.R. (1997) Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture. J. Endocrinol., 152, 59-67.
95. Boyd, A.C., Abdel-Wahab, Y.H., McKillop, A.M., McNulty, H., Barnett, C.R., O'Harte, F.P. and Flatt, P.R. (2000) Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle. Biochim. Biophys. Acta., 1523, 128-134.
96. Abdel-Wahab, Y.H., O'Harte, F.P., Boyd, A.C., Barnett, C.R. and Flatt, P.R. (1997) Glycation of insulin results in reduced biological activity in mice. Acta. Diabetol., 34, 265-270.
97. Hunter, S.J., Boyd, A.C., O'Harte, F.P., McKillop, A.M., Wiggam, M.I., Mooney, M.H., McCluskey, J.T., Lindsay, J.R., Ennis, C.N., Gamble, R., Sheridan, B., Barnett, C.R., McNulty, H., Bell, P.M. and Flatt, P.R. (2003) Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Diabetes, 52, 492-498.
98. Abdel-Wahab, Y.H., O'Harte, F.P., Mooney, M.H., Barnett, C.R. and Flatt, P.R. (2002) Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism, 51, 514-517.
99. Jia, X., Olson, D.J., Ross, A.R. and Wu, L. (2006) Structural and functional changes in human insulin induced by methylglyoxal. Faseb. J., 20, 1555-1557.
100. Tajiri, Y. and Grill, V. (2000) Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1). Int. J. Exp. Diabetes Res., 1, 111-119.
101. Hofmann, S.M., Dong, H.J., Li, Z., Cai, W., Altomonte, J., Thung, S.N., Zeng, F., Fisher, E.A. and Vlassara, H. (2002) Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes, 51, 2082-2089.